Horizon Discovery is a UK Biotechnology company that combines a long scientific heritage in translational research with GENESIS™, a precision gene-editing platform that incorporates rAAV, CRISPR and ZFN technologies. The company supplies genetically-defined cell lines, gene-editing tools and services, custom cell line generation, reporter gene assay kits, molecular reference standards and assay development and screening services to approaching 1,000 organizations engaged in academic research; drug discovery and development, clinical diagnostics, and biopharmaceutical process optimization. Horizon aspires to provide science-driven research solutions that lead to the advancement in the understanding of the genetic basis of disease and better outcomes for patients.
Current Team (18)Update
Funding Rounds (5) - $50.2MUpdate
Calculus Capital creates and manages tax efficient private equity funds for individuals.
Wren Capital is a new seed capital and early stage investment fund based in London. Wren Capital...
Providence Investment Company Limited was added to CrunchBase in 2013
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company...
Life Sciences Investment
7100 Cambridge Research Park
Cambridge, CB25 9TL